Cracking the context-specific PI3K signaling code
暂无分享,去创建一个
[1] Ken Chen,et al. Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations. , 2015, Cancer research.
[2] J. Saez-Rodriguez,et al. A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. , 2014, Angewandte Chemie.
[3] R. Weinberg,et al. Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.
[4] M. Tatsuta,et al. Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia. , 2005, Biochemical and biophysical research communications.
[5] Hernan G. Garcia,et al. Enhancer priming enables fast and sustained transcriptional responses to Notch signaling , 2018, bioRxiv.
[6] Laureline Berteloot,et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome , 2018, Nature.
[7] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[8] W. Hahn,et al. Transformation of Human and Murine Fibroblasts without Viral Oncoproteins , 2005, Molecular and Cellular Biology.
[9] James Briscoe,et al. Gene Regulatory Logic for Reading the Sonic Hedgehog Signaling Gradient in the Vertebrate Neural Tube , 2012, Cell.
[10] K. Yoshida,et al. Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. , 2001, The Biochemical journal.
[11] Nicolai J. Birkbak,et al. Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling , 2017, Nature Communications.
[12] Chad J. Miller,et al. Kinome-wide Decoding of Network-Attacking Mutations Rewiring Cancer Signaling , 2015, Cell.
[13] Jan C. Refsgaard,et al. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites , 2019, Cell.
[14] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[15] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[16] H. Ressom,et al. Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA , 2006, Molecular and Cellular Biology.
[17] Lovelace J. Luquette,et al. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. , 2017, Cancer cell.
[18] R. Milo,et al. Variability and memory of protein levels in human cells , 2006, Nature.
[19] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[20] High-dose oncogenic PIK3CA drives constitutive cellular stemness through self-sustained TGFbeta pathway activation , 2019 .
[21] D. Nimbalkar,et al. Cytokine activation of phosphoinositide 3-kinase sensitizes hematopoietic cells to cisplatin-induced death. , 2003, Cancer research.
[22] T. Graeber,et al. PTEN opposes negative selection and enables oncogenic transformation of pre-B cells , 2016, Nature Medicine.
[23] J. Baselga,et al. Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors , 2016, Clinical Cancer Research.
[24] Ralitsa R. Madsen,et al. Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability , 2019, Biomolecules.
[25] C. Holding,et al. Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.
[26] P. Hawkins,et al. PI3K signalling: the path to discovery and understanding , 2012, Nature Reviews Molecular Cell Biology.
[27] K. Okkenhaug,et al. The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function , 2019, The Journal of Immunology.
[28] A. Bilancio,et al. Signalling by PI3K isoforms: insights from gene-targeted mice. , 2005, Trends in biochemical sciences.
[29] Lewis C. Cantley,et al. Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT Pathway Activity in Cell Populations , 2011, Current Biology.
[30] Ali Najafi,et al. Seminars in Cancer Biology , 2014 .
[31] D J Glass,et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. , 1999, Science.
[32] B. Vanhaesebroeck,et al. Lessons for cancer drug treatment from tackling a non-cancerous overgrowth syndrome , 2018, Nature.
[33] Pauline Traynard,et al. Logic Modeling in Quantitative Systems Pharmacology , 2017, CPT: pharmacometrics & systems pharmacology.
[34] A. Sherman,et al. A mathematical model of metabolic insulin signaling pathways. , 2002, American journal of physiology. Endocrinology and metabolism.
[35] Adam Naguib. Following the trail of lipids: Signals initiated by PI3K function at multiple cellular membranes , 2016, Science Signaling.
[36] Peter Butler,et al. Pulsatile insulin secretion: detection, regulation, and role in diabetes. , 2002, Diabetes.
[37] M. Elowitz,et al. Functional Roles of Pulsing in Genetic Circuits , 2013, Science.
[38] Ralitsa R. Madsen,et al. High-dose oncogenic PIK3CA drives constitutive cellular stemness through self-sustained TGFβ pathway activation , 2019, bioRxiv.
[39] Lewis C. Cantley,et al. The PI3K Pathway in Human Disease , 2017, Cell.
[40] Johan Karlsson,et al. Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration , 2012, Front. Physio..
[41] Shinya Kuroda,et al. Temporal coding of insulin action through multiplexing of the AKT pathway. , 2012, Molecular cell.
[42] M. Boerries,et al. Understanding the mTOR signaling pathway via mathematical modeling , 2017, Wiley interdisciplinary reviews. Systems biology and medicine.
[43] L. Hansen,et al. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis , 2008, Journal of Cell Science.
[44] Julio Saez-Rodriguez,et al. Modeling Signaling Networks to Advance New Cancer Therapies. , 2015, Annual review of biomedical engineering.
[45] Lizhong Liu,et al. Rapid changes in morphogen concentration control self-organized patterning in human embryonic stem cells , 2019, eLife.
[46] Mina Bissell,et al. Reproducibility: The risks of the replication drive , 2013, Nature.
[47] G. Shulman,et al. Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.
[48] Liying Wang,et al. Phosphatidylinositol 3-Kinase/Akt Positively Regulates Fas (CD95)-Mediated Apoptosis in Epidermal Cl41 Cells1 , 2006, The Journal of Immunology.
[49] Mark Merchant,et al. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. , 2012, Cancer research.
[50] C. Betsholtz,et al. Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis. , 2016, Cell stem cell.
[51] C. Kiel,et al. From oncogenic mutation to dynamic code , 2018, Science.
[52] A. Toker,et al. AKT/PKB Signaling: Navigating the Network , 2017, Cell.
[53] P. Bastiaens,et al. Contact inhibitory Eph signaling suppresses EGF-promoted cell migration by decoupling EGFR activity from vesicular recycling , 2018, Science Signaling.
[54] A. Coster,et al. The Akt switch model: Is location sufficient? , 2016, Journal of theoretical biology.
[55] Rugang Zhang,et al. Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. , 2011, Molecular cell.
[56] Dalya R. Soond,et al. Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer , 2016, Nature.
[57] Nir Friedman,et al. Dynamic response diversity of NFAT isoforms in individual living cells. , 2013, Molecular cell.
[58] Andrius Kazlauskas,et al. PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 , 1999, Current Biology.
[59] M. Okabe,et al. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells , 2006, Oncogene.
[60] Tom H. Cheung,et al. p110α of PI3K is necessary and sufficient for quiescence exit in adult muscle satellite cells , 2018, The EMBO journal.
[61] N. Hay,et al. Akt Activation Emulates Chk1 Inhibition and Bcl2 Overexpression and Abrogates G2 Cell Cycle Checkpoint by Inhibiting BRCA1 Foci* , 2010, The Journal of Biological Chemistry.
[62] Benjamin M. Gyori,et al. Encoding Growth Factor Identity in the Temporal Dynamics of FOXO3 under the Combinatorial Control of ERK and AKT Kinases. , 2018, Cell systems.
[63] M. McMahon,et al. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[64] L. Rassenti,et al. Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. , 2016, Blood.
[65] Timothy K Lee,et al. Single-cell NF-κB dynamics reveal digital activation and analogue information processing , 2010, Nature.
[66] Xi C. He,et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.
[67] Dalya R. Soond,et al. Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer , 2014, Nature.
[68] J. Engelman,et al. Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice , 2005, Molecular and Cellular Biology.
[69] Shinya Kuroda,et al. An optogenetic system for interrogating the temporal dynamics of Akt , 2015, Scientific Reports.
[70] N. Ahn,et al. Distinct Cell Cycle Timing Requirements for Extracellular Signal-Regulated Kinase and Phosphoinositide 3-Kinase Signaling Pathways in Somatic Cell Mitosis , 2002, Molecular and Cellular Biology.
[71] A. Saltiel,et al. Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3′-Kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake, Lipogenesis, or Glycogen Synthesis in 3T3-L1 Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[72] B. Kholodenko,et al. The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.
[73] K. Okkenhaug. Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity , 2013, Annals of the New York Academy of Sciences.
[74] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[75] Tobias Meyer,et al. Supplemental Experimental Procedures A Two-Dimensional ERK-AKT Signaling Code for an NGF-Triggered Cell-Fate Decision , 2011 .
[76] F. Meric-Bernstam,et al. Targeting the PI3K pathway in cancer: are we making headway? , 2018, Nature Reviews Clinical Oncology.
[77] K. Okkenhaug,et al. Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy. , 2016, Cancer discovery.
[78] M. Gorospe,et al. Caveolin-Induced Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Increases Arsenite Cytotoxicity , 2003, Molecular and Cellular Biology.
[79] May Yin Lee,et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.
[80] Katharina F. Sonnen,et al. Dynamic signal encoding--from cells to organisms. , 2014, Seminars in cell & developmental biology.
[81] A. Brivanlou,et al. Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4 , 2012, Proceedings of the National Academy of Sciences.
[82] P. Tsichlis,et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[83] S. Baylin,et al. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. , 2014, Molecular cell.
[84] P. Cohen,et al. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.
[85] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[86] Aleksander S. Popel,et al. Endothelial cells decode VEGF-mediated Ca2+ signaling patterns to produce distinct functional responses , 2016, Science Signaling.
[87] E. Lo,et al. Akt and mTOR mediate programmed necrosis in neurons , 2014, Cell Death and Disease.
[88] Hiroyuki Kubota,et al. Decoupling of Receptor and Downstream Signals in the Akt Pathway by Its Low-Pass Filter Characteristics , 2010, Science Signaling.
[89] Moritoshi Sato,et al. Engineered pairs of distinct photoswitches for optogenetic control of cellular proteins , 2015, Nature Communications.
[90] Orion D. Weiner,et al. Illuminating cell signalling with optogenetic tools , 2014, Nature Reviews Molecular Cell Biology.
[91] N. Hay,et al. Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line , 1998, Molecular and Cellular Biology.
[92] Bertram Klinger,et al. Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type-Specific Dynamic Logic Models. , 2017, Cancer research.
[93] M. Rubin,et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors , 2018, Nature.
[94] D. Bray. Protein molecules as computational elements in living cells , 1995, Nature.
[95] C. Martínez-A,et al. Forkhead transcription factors contribute to execution of the mitotic programme in mammals , 2001, Nature.
[96] Peter K. Sorger,et al. Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method , 2015, Nature Communications.
[97] N. Hay,et al. Quantitative Lipid Imaging Reveals a New Signaling Function of Phosphatidylinositol-3,4-Bisphophate: Isoform- and Site-Specific Activation of Akt. , 2018, Molecular cell.
[98] Jared E. Toettcher,et al. Signaling Dynamics Control Cell Fate in the Early Drosophila Embryo. , 2019, Developmental cell.
[99] Jacob J. Hughey,et al. NF-κB signaling dynamics is controlled by a dose-sensing autoregulatory loop , 2019, Science Signaling.
[100] James Briscoe,et al. Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism , 2007, Nature.
[101] Christina S. Leslie,et al. Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs , 2017, Nature Communications.
[102] Amit Kumar,et al. Phosphoinositide 3-Kinases p110α and p110β Regulate Cell Cycle Entry, Exhibiting Distinct Activation Kinetics in G1 Phase , 2008, Molecular and Cellular Biology.
[103] A. Klippel,et al. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.
[104] Sean M. Gross,et al. Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual Fibroblasts* , 2016, The Journal of Biological Chemistry.
[105] John G. Albeck,et al. Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. , 2013, Molecular cell.
[106] K. Polonsky,et al. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.
[107] Alexander Hoffmann,et al. The Dynamics of Signaling as a Pharmacological Target , 2013, Cell.
[108] Aryeh Warmflash,et al. Encoding of temporal signals by the TGF-β pathway and implications for embryonic patterning. , 2014, Developmental cell.
[109] T. Bivona. Dampening oncogenic RAS signaling , 2019, Science.
[110] P. Sorger,et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.
[111] A. Warmflash,et al. Synergy with TGFβ ligands switches WNT pathway dynamics from transient to sustained during human pluripotent cell differentiation , 2019, Proceedings of the National Academy of Sciences.
[112] Annie Z. Tremp. Malaria: Plasmodium develops in lymph nodes , 2006, Nature Reviews Microbiology.
[113] M. Elowitz,et al. Dynamic Ligand Discrimination in the Notch Signaling Pathway , 2018, Cell.
[114] I. Komuro,et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21‐dependent pathway , 2004, The EMBO journal.
[115] O. Delpuech,et al. Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA-Dependent Breast Cancers , 2016, Molecular Cancer Therapeutics.
[116] N. Hay,et al. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.
[117] N. Hay,et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. , 1997, Genes & development.
[118] David E. James,et al. Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes* , 2011, The Journal of Biological Chemistry.
[119] S. Rafii,et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells , 2010, Nature Cell Biology.
[120] L. Rubin,et al. Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons , 1997, The Journal of cell biology.
[121] E. Tran,et al. Deletion of the Imprinted Gene Grb10 Promotes Hematopoietic Stem Cell Self-Renewal and Regeneration. , 2016, Cell reports.
[122] Zhihui Wang,et al. Dynamic Targeting in Cancer Treatment , 2019, Front. Physiol..
[123] Jackelyn A. Alva,et al. EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Phosphatase and Tensin Homolog Regulates the Pluripotent State and Lineage Fate Choice in Human Embryonic Stem Cells , 2011 .
[124] Jared E. Toettcher,et al. Light-based feedback for controlling intracellular signaling dynamics , 2011, Nature Methods.
[125] B. Kholodenko. Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.
[126] T. Meyer,et al. A PI3-Kinase Signaling Code for Insulin-Triggered Insertion of Glucose Transporters into the Plasma Membrane , 2002, Current Biology.
[127] C. Yau,et al. Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma , 2019, Nature Communications.
[128] Ralitsa R. Madsen,et al. Cancer-Associated PIK3CA Mutations in Overgrowth Disorders , 2018, Trends in molecular medicine.
[129] ChangHwan Lee,et al. Dynamics of Notch-Dependent Transcriptional Bursting in its Native Context , 2018, bioRxiv.
[130] B. Sloth,et al. Effective ‘ Activated PI 3 K δ Syndrome ’-targeted therapy with the PI 3 K δ inhibitor leniolisib Running head : Effective therapy of APDS by PI 3 K δ inhibitor leniolisib , 2017 .
[131] D. Stokoe,et al. A Role for PI 3-Kinase and PKB Activity in the G2/M Phase of the Cell Cycle , 2002, Current Biology.
[132] Uri Alon,et al. Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.
[133] I. Majewski. On fitness: how do mutations shape the biology of cancer? , 2019, Biochemical Society transactions.
[134] T. Fujimiya,et al. Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2 , 2003, Oncogene.
[135] R. Pearson,et al. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy , 2011, Oncogene.
[136] J. Gribben,et al. Empirical inference of circuitry and plasticity in a kinase signaling network , 2015, Proceedings of the National Academy of Sciences.
[137] Shinya Kuroda,et al. In Vivo Decoding Mechanisms of the Temporal Patterns of Blood Insulin by the Insulin-AKT Pathway in the Liver. , 2018, Cell systems.
[138] A. Eastman,et al. Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer , 2016, Clinical Cancer Research.
[139] B. Vanhaesebroeck,et al. PI3K isoforms in cell signalling and vesicle trafficking , 2019, Nature Reviews Molecular Cell Biology.
[140] Lucas Pelkmans,et al. Multiplexed protein maps link subcellular organization to cellular states , 2018, Science.
[141] Gerald R. V. Hammond,et al. Genetically encoded lipid biosensors , 2018, Molecular biology of the cell.
[142] S. Beronja,et al. Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth , 2018, Nature Cell Biology.
[143] W. Zong,et al. Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition* , 2009, The Journal of Biological Chemistry.
[144] Michael B. Stadler,et al. PIK3CAH1047R induces multipotency and multi-lineage mammary tumours , 2015, Nature.
[145] S. Chandarlapaty,et al. Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling. , 2014, Cancer discovery.
[146] L. Cantley,et al. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate , 1988, Nature.
[147] Peter K. Sorger,et al. Sporadic ERK pulses drive non-genetic resistance in drug-adapted BRAFV600E melanoma cells , 2019, bioRxiv.
[148] A. Klippel,et al. Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation , 1998, Molecular and Cellular Biology.
[149] G. Lahav,et al. Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.
[150] Jared E. Toettcher,et al. Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway , 2018, Science.
[151] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[152] G. Cooper,et al. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.
[153] M. Inoue,et al. Activation of insulin-like growth factor signaling induces apoptotic cell death under prolonged hypoxia by enhancing endoplasmic reticulum stress response. , 2007, Cancer research.
[154] D. Voskas,et al. Activation of PDK-1 maintains mouse embryonic stem cell self-renewal in a PKB-dependent manner , 2013, Oncogene.
[155] Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner , 2018 .
[156] Sean M. Gross,et al. Mapping growth-factor-modulated Akt signaling dynamics , 2016, Development.
[157] Takeshi Norimatsu,et al. Encoding and Decoding , 2016 .
[158] C. Heisenberg,et al. Optogenetic Control of Nodal Signaling Reveals a Temporal Pattern of Nodal Signaling Regulating Cell Fate Specification during Gastrulation. , 2016, Cell reports.
[159] Benjamin Lin,et al. Toward total synthesis of cell function: Reconstituting cell dynamics with synthetic biology , 2016, Science Signaling.
[160] I. Greenwald,et al. A Real-Time Biosensor for ERK Activity Reveals Signaling Dynamics during C. elegans Cell Fate Specification. , 2017, Developmental cell.
[161] Hiroyuki Kubota,et al. A Quantitative Image Cytometry Technique for Time Series or Population Analyses of Signaling Networks , 2010, PloS one.
[162] Phillip G. Montgomery,et al. Defining a Cancer Dependency Map , 2017, Cell.